Artwork for Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O'Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute
What2Know - a Marketing and Communications Podcast

Supporting Early Stage Immunotherapy Research to Fuel Breakthroughs in Cancer Treatment: Jill O'Donnell-Tormey, Ph.D., CEO & Director of Scientific Affairs, Cancer Research Institute
00:00:00 / 00:26:32